来自MSN3 个月
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...
Medscape22 天
Paclitaxel-Induced Sickle Cell Crisis
Purpose: A case of paclitaxel-induced painful crisis in a patient with breast cancer and hemoglobin sickle cell disease (SCD) is reported. Summary: A 55-year-old postmenopausal African-American ...